Inclusion criteria: |
1. Age 13–18 |
2. As assessed by Kiddie-Schedule for Affective Disorders and Schizophrenia (K-SADS-PL), it meets the DSM-5 criteria for MDD with non-psychotic symptoms |
3. Score ≥ 40 on the CDRS-R |
4. Participants with suicidal ideation are eligible, as long as clinicians consider outpatient treatment to be safe |
5. Sufficient audio-visual level to complete this study |
6. Written informed consent was obtained from patients and at least one of their parents |
Exclusion criteria: |
1. History of bipolar disorder, schizophrenia, autism, eating disorders, primary obsessive compulsive disorder, pervasive developmental disorder, or psychosis not otherwise specified |
2. History of serious physical illnesses |
3. Substance abuse or dependence |
4. Current depressive episode with clear suicidal plans or behaviors |
5. Requires inpatient treatment for psychiatric disorders |
6. Patients with severe mental illness requiring immediate hospitalization |
7. Two or more failed trials of antidepressant drugs: each trial for at least 8 weeks, with the last 4 weeks at full dose (e.g. fluoxetine 40Â mg/d, citalopram 40Â mg/d, escitalopram 20Â mg/d, sertraline 150Â mg/d) |
8. History of clear-cut intolerability of, or lack of effect with, an adequate trial of at least one protocol treatment option |
9. Taking any medicine that contraindicates in combination with or interferes with the efficacy of the treatment |
10. Taking or administering antidepressants within 5 half-lives |
11. Received modified electroconvulsive therapy within 12 months |
12. Female patients with pregnancy |